Prascend (Pergolide mesylate) is filed as Dopamine agonist. The sections below restate public label fields stored for this profile.
Treatment of clinical signs of PPID (equine Cushing's disease) in horses
Stimulates dopamine receptors in the pituitary gland, suppressing excessive ACTH secretion from the pars intermedia.
Start at low dose and titrate based on ACTH levels. May cause decreased appetite initially — start during good weather when pasture is available.
Specific contraindication data for this veterinary product may not be available in public databases. Consult your veterinarian before use.
Decreased appetite (Common initially); Lethargy (Occasional); Diarrhea (Occasional)
Starting dose: 2 mcg/kg orally once daily. Titrate based on clinical response and ACTH testing every 3-6 months.
Limited structured drug interaction data is available from public sources for this veterinary product. Consult your veterinarian about potential interactions with other medications.
According to its FDA label, Prascend (Pergolide mesylate) is approved for: Treatment of clinical signs of PPID (equine Cushing's disease) in horses For medical advice, please talk to your prescriber or pharmacist.
Prascend (Pergolide mesylate) belongs to the Dopamine agonist class of medications.
Not yet. As of the most recent FDA data we ingest, no A-rated generic equivalent is listed for Prascend. Availability changes as patents expire.
Our ingest of the FDA label for Prascend (Pergolide mesylate) does not include a Boxed Warning at this time. See the full label on DailyMed for the current, authoritative version.
Public CMS NADAC pricing for Prascend (Pergolide mesylate) is in the range Retail prices vary widely by pharmacy, insurance, and location. Check with your pharmacy or use tools like GoodRx for current pricing.. Retail price varies by pharmacy, insurance, and manufacturer coupons.
The FDA Enforcement Report does not show an active/ongoing recall for Prascend (Pergolide mesylate) in our latest ingest. Recall data can change daily — verify at FDA.gov.
The FDA label lists Boehringer Ingelheim as a labeler/manufacturer of Prascend (Pergolide mesylate). Multiple firms may market generics of the same molecule.
The FDA label states: "Store at controlled room temperature. Protect from moisture." Follow the packaging insert for the authoritative guidance.
Loading full data from Know Your Drugs Institute…